| 1. |
- Georgakis, Marios K., et al.
(författare)
-
Malignant Central Nervous System Tumors Among Adolescents and Young Adults (15-39 Years Old) in 14 Southern-Eastern European Registries and the US Surveillance, Epidemiology, and End Results Program: Mortality and Survival Patterns
- 2017
-
Ingår i: Cancer. - : WILEY. - 0008-543X .- 1097-0142. ; 123:22, s. 4458-4471
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: Unique features and worse outcomes have been reported for cancers among adolescents and young adults (AYAs; 15-39 years old). The aim of this study was to explore the mortality and survival patterns of malignant central nervous system (CNS) tumors among AYAs in Southern-Eastern Europe (SEE) in comparison with the US Surveillance, Epidemiology, and End Results (SEER) program. METHODS: Malignant CNS tumors diagnosed in AYAs during the period spanning 1990-2014 were retrieved from 14 population-based cancer registries in the SEE region (n = 11,438). Age-adjusted mortality rates were calculated and survival patterns were evaluated via Kaplan-Meier curves and Cox regression analyses, and they were compared with respective 1990-2012 figures from SEER (n = 13,573). RESULTS: Mortality rates in SEE (range, 11.9-18.5 deaths per million) were higher overall than the SEER rate (9.4 deaths per million), with decreasing trends in both regions. Survival rates increased during a comparable period (2001-2009) in SEE and SEER. The 5-year survival rate was considerably lower in the SEE registries (46%) versus SEER (67%), mainly because of the extremely low rates in Ukraine; this finding was consistent across age groups and diagnostic subtypes. The highest 5-year survival rates were recorded for ependymomas (76% in SEE and 92% in SEER), and the worst were recorded for glioblastomas and anaplastic astrocytomas (28% in SEE and 37% in SEER). Advancing age, male sex, and rural residency at diagnosis adversely affected outcomes in both regions. CONCLUSIONS: Despite definite survival gains over the last years, the considerable outcome disparities between the less affluent SEE region and the United States for AYAs with malignant CNS tumors point to health care delivery inequalities. No considerable prognostic deficits for CNS tumors are evident for AYAs versus children. (c) 2017 American Cancer Society.
|
|
| 2. |
- Papanikolaou, Konstantinos, et al.
(författare)
-
The Yo-Yo intermittent endurance level 2 test: reliability of performance scores, physiological responses and overload characteristics in competitive soccer, basketball and volleyball players
- 2019
-
Ingår i: Journal of Human Kinetics. - : Termedia Sp. z.o.o.. - 1640-5544 .- 1899-7562. ; 67:1, s. 223-233
-
Tidskriftsartikel (refereegranskat)abstract
- The purpose of this study was to evaluate the reliability and reproducibility of the physiological and overload features of the Yo-Yo intermittent endurance test level 2 (Yo-Yo IE2) in competitive male soccer (n = 20), basketball (n = 11), and volleyball players (n = 10). The participants completed Yo-Yo IE2 tests on three separate occasions with assessment of performance, heart rate, running speed, accelerations, decelerations and body load using GPS instrumentation. The intra-class correlation coefficient index, confidence intervals and coefficients of variation were calculated to assess the reliability of the test. Intra-class correlation coefficients for test-retest trials in the total sample ranged from large to nearly perfect (total distance: 0.896; mean speed: 0.535; maximum speed: 0.715; mean HR: 0.876; maximum HR: 0.866; body load: 0.865). The coefficients of variation for distance, mean speed, HR response, as well as acceleration and deceleration scores for test-retest trials ranged from 1.2 to 12.5% with no differences observed among particular sport disciplines. The CV for shuttles performed ranged from 4.4 to 5.5% in all sports. Similar results were obtained for the three different categories of players tested. These results suggest that the Yo-Yo IE2 test appears to be a reliable alternative for evaluating the ability to perform intermittent high-intensity running in different outdoor and indoor team sports. Players may need one or two familiarization tests to ensure valid assessment of intermittent endurance capacity. It appears that the Yo-Yo IE2 test incorporates accelerations and decelerations in a consistent and reproducible fashion.
|
|
